Tyr Pharma stock rated Hold after mixed trial results for efzofitimod; promising secondary data, but there remains uncertainty. Find out why ATYR is a Hold.

Hormonal changes associated with menopause may influence the clinical presentation of systemic sclerosis (SSc), according to study findings published in Therapeutic Advances in Musculoskeletal Disease ...

The thinning of retinal layers detected with OCT could offer a view into progression independent of relapse activity, an ...

From asthma to chronic obstructive pulmonary disease (COPD), there are a variety of conditions that can affect the lungs. Wheezing or general shortness of breath may be signs that the lungs aren’t ...